New drugs change obesity treatment

New medications for obesity work by targeting the body's appetite and satiety signals, leading to significant reductions in food intake. These drugs have shifted the approach from advising people to eat less and exercise more to using medical interventions that reduce hunger.

Weight loss may not mean health gain

While these treatments can lead to weight loss, they do not always improve overall health. The weight lost may include muscle mass, which is important for strength and independence, especially as people age. This means that a lower weight on the scale does not necessarily indicate better health.

Risk of malnutrition and muscle loss

Some patients may consume so little food that they risk becoming malnourished or losing muscle mass. For example, a person who needs 1,300 kcal per day but only consumes 700 kcal under treatment may experience muscle loss and weakened physical abilities, even while remaining overweight.

Psychological challenges of new eating habits

The psychological impact of these drugs can be significant. Patients who have spent years eating less to manage their weight may struggle with the new need to eat more, even when they are no longer hungry. This shift can create confusion and anxiety about food and weight.

Nutritional support remains essential

These drugs are not a substitute for proper nutrition. Patients may need a balanced diet, adequate protein, regular physical activity, and personalized dietary guidance to prevent muscle loss and ensure overall health. Multivitamins alone are not sufficient to address these needs.

Long-term use raises questions

There are still many unanswered questions about the long-term use of these drugs. Studies show that weight can return after stopping treatment, leading to concerns about whether these medications will need to be used for years or even a lifetime. The long-term health effects remain unclear.